Ba Ji Tian

Morinda officinalis How.

Also known as: Morinda root(English) 巴戟天(Chinese)

Pageukcheon巴戟天 파극천 Ba kích Pa Chi T'ien

Updated October 5, 2026 · Not yet clinically reviewed

Safety at a glance

Caution

4 recorded drug interactions, 1 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
tonifying
Temperature
Warm
Taste
Pungent,Sweet
Channels
Kidney,Liver

Functions

Tonifies Kidney Yang; Strengthens the Sinews and Bones; Dispels Wind-Dampness; Nourishes Essence and Blood

Traditional uses

Ba Ji Tian (morinda root) is a warm, sweet-pungent herb that powerfully supplements Kidney Yang and expels Wind-Cold-Damp from the bones and sinew. It is used for impotence, urinary frequency, and infertility from Kidney Yang deficiency, as well as lower back pain, joint stiffness, and tendon weakness from Wind-Cold-Damp bi obstruction on a foundation of Kidney deficiency. Its combined tonifying and expelling properties make it valuable when both deficiency and obstruction co-exist in the lower body.

Western herbalism

Pharmacological effects

  • Anti-granulation: Aqueous extract at 10-80 g/kg orally or i.p. inhibited plastic ring-induced granulation in rats.
  • Hypothalamus-pituitary-ovary stimulation: At 1 g/kg orally it enhanced this axis in animals, promoting corpus luteum formation and ovulation.
  • ACTH-like action: 50% alcoholic extract (oral or i.p.) caused thymus atrophy in young mice.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 593.

Formulas using this herb

14 of 14 formulas

Botanical

Morinda officinalis is an evergreen climbing or scrambling shrub in the Rubiaceae, native to southern China and northern Vietnam, where it grows in lowland and lower montane forest, often on shaded slopes and along forest margins. The slender, twining stems can reach several metres in length and bear opposite, elliptic to oblong-lanceolate leaves 6-15 cm long, with entire margins, an acute to acuminate tip and conspicuous interpetiolar stipules characteristic of the family. The fleshy root system is unusual: long, cylindrical roots are repeatedly constricted at irregular intervals, giving them a distinctive moniliform or beaded appearance, with a thick, purplish-brown bark and a paler core. Small, white to pale pinkish, four- to five-lobed tubular flowers are produced in dense terminal or axillary heads. These develop into compound, fleshy, multiple fruits 5-10 mm across, ripening to a bright orange-red colour. It is cultivated commercially in Guangdong and Guangxi.

Family
Rubiaceae
Pharmaceutical name
Radix Morindae Officinalis
Parts used
root
Plant type
vine
Native region
Guangdong, Guangxi

Constituents

Inulin-type oligosaccharides (bajijiasu, nystose, 1F-fructofuranosylnystose, kestose, sucrose)

Fructo-oligosaccharide · the quantitatively dominant constituent class of the root; more than 20 individual oligosaccharides have been isolated

The fraction behind the herb's best-supported modern indication. Morinda officinalis oligosaccharides (MOO) are licensed in China as an antidepressant preparation, and a meta-analysis of seven randomised trials found MOO capsules non-inferior to conventional antidepressants for mild to moderate depression. Bajijiasu, a dimeric fructose from this fraction, also inhibits RANKL-induced osteoclast formation in vitro.

Monotropein

Iridoid glycoside · the principal iridoid, reported at over 1% of the dried root

Isolated monotropein at 40-80 mg/kg/day for four weeks increased bone mineral content and density and improved trabecular microarchitecture in ovariectomised mice, supporting the traditional use for the sinews and bones. Also reported to be anti-inflammatory.

Deacetylasperulosidic acid, asperuloside and asperulosidic acid

Iridoid glycosides

The other major iridoids of the root. Together with monotropein they form the iridoid fingerprint used to distinguish Morinda officinalis from Morinda citrifolia and other Rubiaceae substitutes.

Rubiadin and rubiadin-1-methyl ether

Anthraquinone · a minor fraction; roughly 28 anthraquinones have been described from the root

Anthraquinones from Morinda officinalis suppressed osteoclastic bone resorption in vitro, reducing resorption pit formation and multinucleated osteoclast numbers. Rubiadin is also a mutagenic hydroxyanthraquinone in bacterial assays, which is the basis for not treating high-dose long-term anthraquinone exposure from any Rubiaceae or Polygonaceae root as automatically benign.

Physcion

Anthraquinone

A methylated anthraquinone of the root, used with rubiadin as an HPLC marker; contributes to the antioxidant and osteoclast-inhibiting activity attributed to the anthraquinone fraction.

Polysaccharides

Polysaccharide

Bioassay-guided work has attributed part of the root's anti-osteoporotic activity to its polysaccharide fraction, which protected against bone loss in ovariectomised rats.

Drug interactions

Morinda citrifolia (noni) root or fruit - documented substitute species

Major · Wrong species dispensed; noni carries reported hepatotoxicity and, because of its high potassium content, hyperkalaemia risk in renal impairment · Evidence level: Established

Morinda officinalis is heavily adulterated because wild supply is limited and demand is high, and its congener Morinda citrifolia is one of the substitutes met in trade. The two are chemically separable: UPLC/Q-TOF-MS with multivariate analysis shows distinct anthraquinone, iridoid glycoside and triterpenoid profiles, so a fingerprint will detect the swap. The clinical hazard is not inertness but the substitute's own toxicology - noni juice has been reported to cause hyperkalaemia in a patient with chronic renal insufficiency (measured potassium concentration 56.3 mEq/L in the juice, comparable to orange or tomato juice), and multiple hepatotoxicity case reports exist for noni preparations.

Clinical note: Buy Ba Ji Tian from a supplier that provides species authentication. Avoid unauthenticated Morinda material altogether in patients with chronic kidney disease, on ACE inhibitors, ARBs, potassium-sparing diuretics or potassium supplements, or with any liver disease.

Morinda umbellata (Yang Jiao Teng, sold as Jian Ba Ji) - documented adulterant

Moderate · Therapeutic failure; the prescribed Kidney-Yang tonic effect is simply absent · Evidence level: Established

Morinda umbellata is the commonest adulterant of Ba Ji Tian in Chinese markets. It is distinguishable on macroscopic examination: the bark layer is thinner, the woody core occupies roughly 60-70% of the root diameter (against less than a third in authentic material), and the taste is bland and faintly sweet rather than sweet with a slight astringency. ITS2 DNA barcoding separates Morinda officinalis from its confused species where morphology is ambiguous.

Clinical note: Inspect the transverse section: a woody core taking up most of the diameter means it is not Ba Ji Tian. The Pharmacopoeial drug is also processed by removing the woody core, so a high core fraction indicates both wrong species and inadequate processing.

Damnacanthus indicus and Damnacanthus officinarum (Hu Ci, sold as En Shi Ba Ji or Jia Ba Ji) - documented adulterants

Moderate · Therapeutic failure with an unstudied Rubiaceae root substituted · Evidence level: Established

Damnacanthus roots are the other recognised counterfeit group. They form a beaded, constricted shape naturally rather than through processing, taste bitter-sweet, and are harder in texture than genuine Ba Ji Tian. Their own pharmacology and toxicology are poorly characterised, so a patient given them is taking an essentially unstudied herb.

Clinical note: Beading that is uniform and natural-looking, with a hard texture and bitter taste, should trigger rejection of the batch.

Antidepressants (SSRIs, SNRIs) and other serotonergic drugs

Theoretical · Additive antidepressant effect; theoretical additive serotonergic burden · Evidence level: Possible

Morinda officinalis oligosaccharide capsules are a licensed antidepressant in China and performed comparably to conventional antidepressants in a meta-analysis of seven trials in 1384 participants; a 2025 randomised trial combined MOO with probiotics in major depressive disorder. Combination with a conventional antidepressant has not been formally studied for interaction, and no case of serotonin syndrome attributable to Morinda has been reported, so this is a pharmacodynamic inference from efficacy data, not an observed interaction.

Clinical note: Do not present Ba Ji Tian to a patient as a reason to reduce or stop a prescribed antidepressant. If MOO is added to an SSRI, coordinate with the prescriber and watch for agitation, tremor or sweating.

Dosage

FormAmountFrequencyNotes
decoction3–10 gDaily
中国药典 2020 【用法与用量】3~10g。 【性味与归经】甘、辛,微温。归肾、肝经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence

Study design on record, not certainty of outcome.

Systematic review / meta-analysis
1
Other clinical trial
1
Observational / case report
1
In vitro / animal
3

Efficacy and safety of Morinda officinalis oligosaccharide capsules for depressive disorder: a systematic review and meta-analysis

Du Y, Zheng Q, Ou ZH, Cao YJ, Su XP, Li C, Qu M · Brazilian Journal of Psychiatry · 2021 · systematic review

Systematic review / meta-analysis · Verified

Seven randomised controlled trials with 1384 participants were pooled. Morinda officinalis oligosaccharide capsules were not inferior to conventional antidepressants for mild to moderate depressive disorder, with no significant difference in adverse events. The authors noted that the trial quality was limited and called for further high-quality studies.

doi:10.1590/1516-4446-2020-0945

Efficacy and Safety of Morinda Officinalis Oligosaccharides Combined with Probiotics as a Therapeutic Strategy for Major Depressive Disorder with Gastrointestinal Symptoms: A Randomized, Double-Blind, Controlled Clinical Trial

Zhou J, Wang X, Wang R, Deng Y, Lyu N, Li R, Li X, Liu J, Yang J, Zhou J, Wang G · Neuropsychiatric Disease and Treatment · 2025 · RCT

Other clinical trial · Verified

Eight-week randomised, double-blind trial in 108 patients with major depressive disorder and gastrointestinal symptoms comparing Morinda officinalis oligosaccharides plus probiotics against Morinda officinalis oligosaccharides plus placebo. Adverse events occurred in 5.56% of each arm with no serious events and no manic switching. Both arms received the oligosaccharide preparation, so the trial tests the probiotic add-on rather than the herb against placebo.

doi:10.2147/ndt.s534858

Noni juice (Morinda citrifolia ): Hidden potential for hyperkalemia?

Mueller BA, Scott MK, Sowinski KM, Prag KA · American Journal of Kidney Diseases · 2000 · cohort

Observational / case report · Verified

Case report of hyperkalaemia in a man with chronic renal insufficiency who self-medicated with noni juice while claiming adherence to a low-potassium diet; the juice measured 56.3 mEq/L potassium. Relevant to Ba Ji Tian only because Morinda citrifolia is a documented substitute species, and it is why unauthenticated Morinda material is unsafe in renal impairment.

doi:10.1016/s0272-6386(00)70342-8

Monotropein isolated from the roots of Morinda officinalis increases osteoblastic bone formation and prevents bone loss in ovariectomized mice

Zhang Z, Zhang Q, Yang H, Liu W, Zhang N, Qin L, Xin H · Fitoterapia · 2016 · animal

In vitro / animal · Verified

Monotropein at 40 or 80 mg/kg/day for four weeks increased bone mineral content, bone mineral density and bone volume fraction and improved trabecular microarchitecture in ovariectomised mice, promoting osteoblastic bone formation. Provides a defined active constituent for the traditional indication of strengthening the sinews and bones.

doi:10.1016/j.fitote.2016.03.013

Inhibitory Effects of Morinda officinalis Extract on Bone Loss in Ovariectomized Rats

Li N, Qin LP, Han T, Wu YB, Zhang QY, Zhang H · Molecules · 2009 · animal

In vitro / animal · Verified

Morinda officinalis extract given for twelve weeks protected ovariectomised rats against bone loss, deterioration of trabecular microarchitecture and loss of bone biomechanical strength.

doi:10.3390/molecules14062049

Comparison of Anthraquinones, Iridoid Glycosides and Triterpenoids in Morinda officinalis and Morinda citrifolia Using UPLC/Q-TOF-MS and Multivariate Statistical Analysis

Wang M, Wang Q, Yang Q, Yan X, Feng S, Wang Z · Molecules · 2019 · in vitro

In vitro / animal · Not yet verified

UPLC/Q-TOF-MS with multivariate statistics separated Morinda officinalis from Morinda citrifolia on their anthraquinone, iridoid glycoside and triterpenoid profiles. This is the analytical basis for detecting substitution of noni material for Ba Ji Tian.

doi:10.3390/molecules25010160

Safety

Contraindications

Its use is prohibited in patients with vigorous fire due to yin deficiency or fever.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 344–356.

Cultural and historical

Shen Nong Ben Cao Jing · Han dynasty (c. 200 CE)

Ba Ji Tian is entered among the upper-class medicinals, recorded for Wind evil, impotence and strengthening the sinews, bones and will - the origin of its later classification as a Kidney-Yang tonic.

Ben Cao Gang Mu · Ming dynasty (Li Shi-zhen, 1596)

Records the drug's preparation and its use for Kidney deficiency with cold, and describes the practice of removing the woody core of the root before use, which remains the Pharmacopoeial processing step and a marker of authentic material.

References

  1. Zhang JH, Xin HL, Xu YM, Shen Y, He YQ, Hsien-Yeh, Lin B, Song HT, Juan-Liu, Yang HY, Qin LP, Zhang QY, Du J. Morinda officinalis How. – A comprehensive review of traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology. 2018 doi:10.1016/j.jep.2017.10.028
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice